Evidence map›Paper›PMID 41408204›Full record

ArticleBMC neurology2025

Physical activity and its effects in myasthenia gravis: a patient-reported study on habits and impact.

Stefanie Glaubitz, Stefanie Meyer, Johanna Loris, Rachel Zeng, Karsten Kummer, Tania Garfias-Veitl, Ariana Seraji, Lina Hassoun, Denise Rohleder, Ina Hunger and 1 more

Abstract read
In one paragraph

Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefanie GlaubitzDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany. stefanie.glaubitz@med.uni-goettingen.de.
Stefanie MeyerDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.
Johanna LorisDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.
Rachel ZengDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.
Karsten KummerDepartment of Neurology and Pain Treatment, Immanuel Clinic Rüdersdorf, University Hospital of the Brandenburg Medical School Theodor Fontane, Rüdersdorf bei Berlin, Germany.
Tania Garfias-VeitlDepartment of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
Ariana SerajiDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.
Lina HassounDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.
Denise RohlederInstitute of Sport, University Bremen, Bremen, Germany.
Ina HungerInstitute of Sport, University Bremen, Bremen, Germany.
Jana ZschüntzschDepartment of Neurology, University Medical Center Göttingen, Robert-Koch-Straße 40, Göttingen, 37075, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPhysical activity and exercise have been classified as safe and effective in mild to moderate cases of myasthenia gravis (MG) across various studies. Subsequently, adequate physical activity is generally recommended. Nevertheless, individuals with MG remain less physically active than the general population, without a precise definition of the low-activity group so far.

methodsIn this prospective single-center study, individuals with MG completed a questionnaire assessing general mobility, weekly physical activity levels, and beliefs toward specific statements about physical exercise. These data were contextualized with clinical parameters and MG-specific scores.

resultsAmong 84 individuals (50% female), 73.8% reported general positive effects, and 77.4% noted improvements in mood and well-being due to physical activity. No significant differences in physical activity levels were found depending on sex, BMI or age. Weekly physical activity averaged 94.6 min (SD: 85.6), falling below current recommendations. Physical activity was inversely correlated with lower QMG (p = 0.019) and MG-ADL scores (p = 0.004). Despite the reported positive impact of physical activity on quality of life, no relevant connection was detected between physical activity and MG-QoL15 scores. Barriers preventing individuals affected by MG from engaging in physical activity included muscle pain (35.4%) and motivational challenges (22%). Individuals with motivational problems were younger (mean age 55.5 vs. 66.6 years, p = 0.011) and more frequently reported depressive symptoms; no other significant differences were observed in gender or disease severity in this subgroup.

conclusionIndividuals with MG perceive physical activity as beneficial to their physical well-being, mood, and overall quality of life. Those with less severe disease tend to be more active. However, barriers such as motivational issues and post-exercise pain must be addressed. Clinicians should aim to identify individuals with low activity levels, encourage engagement in physical activity, highlight its benefits, and alleviate patient concerns.

trial registrationStudy approval by the Ethics Committee of the University Medical Center Göttingen was granted (number 33/12/21). The study was retrospectively registered at the German Clinical Trial Registry (DRKS) under the study ID DRKS00033171 (Date of trial registration December 1st, 2023).

Indexed as

ExerciseHabitsMyasthenia GravisQuality of LifeAdultAgedFemaleHumansMaleMiddle AgedPatient Reported Outcome MeasuresProspective StudiesSurveys and QuestionnairesExerciseMG-ADLMyasthenia gravisPhysical activityQMGQuality of life

Identifiers

PMID41408204
PMCPMC12822234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.